Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
A Trio of Fast Growing Revenue Stock Picks
09:45am, Monday, 11'th Jan 2021
The S&P 500 stocks saw their aggregate trailing 12-month real revenue per share rise at a compound average growth rate (CAGR) of nearly 2% per annum over the past five years. The share price of the be
Axogen to Participate at AAHS ASPN ASRM 2021 Virtual Annual Meetings
07:00am, Tuesday, 05'th Jan 2021
Clinical evidence supporting the company's platform for nerve repair will be featured in several presentations during the scientific sessions Clinical evidence supporting the company's platform for ne
Axogen Sponsors Donate Life at 2021 Virtual Rose Parade Celebration
07:00am, Wednesday, 23'rd Dec 2020
ALACHUA, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves,
AxoGen: Operating Efficiencies Come Through The P&L And Cash-flow Statement
08:08pm, Sunday, 20'th Dec 2020
AxoGen: Operating Efficiencies Come Through The P&L And Cash-flow Statement
Axogen, Inc. to Participate at Jefferies Virtual London Healthcare Conference and Canaccord Genuity Virtual MedTech & Diagnostics Forum
07:00am, Wednesday, 04'th Nov 2020
ALACHUA, Fla., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves,
Axogen, Inc. Reports Third Quarter 2020 Financial Results
04:01pm, Thursday, 29'th Oct 2020
ALACHUA, Fla., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported fi
AxoGen (NASDAQ:AXGN) Stock Rating Upgraded by BidaskClub
04:12am, Sunday, 18'th Oct 2020
AxoGen (NASDAQ:AXGN) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Friday, BidAskClub reports. Several other research a
AxoGen (AXGN) Receives a Hold from Canaccord Genuity - Markets
04:44pm, Tuesday, 13'th Oct 2020
Canaccord Genuity analyst Kyle Rose maintained a Hold rating on AxoGen (AXGN – Research Report) on October 11 and set
AxoGen Struggling Through A Protracted Restructuring (NASDAQ:AXGN)
06:34am, Friday, 02'nd Oct 2020
COVID-19 has complicated a sales restructuring effort that was already severely testing the patience of investors, as the company looks to refocus on its core trauma opportunity.
Axogen, Inc. Appoints Paul G. Thomas to Board of Directors
08:01pm, Wednesday, 30'th Sep 2020
ALACHUA, Fla., Sep 30, 2020 (GLOBE NEWSWIRE via COMTEX) --
Healthcare veteran brings 30+ years of medtech experience to Axogen, Inc. Board of Directors...
Axogen, Inc. Appoints Paul G. Thomas to Board of Directors
08:01pm, Wednesday, 30'th Sep 2020
ALACHUA, Fla., Sep 30, 2020 (GLOBE NEWSWIRE via COMTEX) -- Healthcare veteran brings 30+ years of medtech experience to Axogen, Inc. Board of Directors...
Jacobs Levy Equity Management Inc. Purchases New Stake in AxoGen, Inc (NASDAQ:AXGN)
07:24am, Monday, 21'st Sep 2020
Jacobs Levy Equity Management Inc. acquired a new position in AxoGen, Inc (NASDAQ:AXGN) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). Th
Is AxoGen's (NASDAQ:AXGN) 219% Share Price Increase Well Justified?
01:48pm, Friday, 07'th Aug 2020
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...
AxoGen (AXGN) Reports Q2 Loss, Tops Revenue Estimates
11:45pm, Wednesday, 05'th Aug 2020
AxoGen (AXGN) delivered earnings and revenue surprises of 40.00% and 5.31%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Axogen, Inc. Reports Second Quarter 2020 Financial Results
08:01pm, Wednesday, 05'th Aug 2020
ALACHUA, Fla., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported fi
